Link-Gelles R, Ciesla AA, Mak J, Miller JD, et al. Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Pro MMWR Morb Mortal Wkly Rep 2024;73:77-83.
PMID: 38300853